pMXs-hSOX2 Citations (105)
Originally described in: Induction of pluripotent stem cells from adult human fibroblasts by defined factors.Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S Cell. 2007 Nov 30. 131(5):861-72. PubMed Journal
Articles Citing pMXs-hSOX2
| Articles |
|---|
| Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. Byrne JA, Nguyen HN, Reijo Pera RA. PLoS One. 2009 Sep 23;4(9):e7118. doi: 10.1371/journal.pone.0007118. PubMed |
| Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. Moretti A, Bellin M, Jung CB, Thies TM, Takashima Y, Bernshausen A, Schiemann M, Fischer S, Moosmang S, Smith AG, Lam JT, Laugwitz KL. FASEB J. 2010 Mar;24(3):700-11. doi: 10.1096/fj.09-139477. Epub 2009 Oct 22. PubMed |
| Human-induced pluripotent stem cells: derivation, propagation, and freezing in serum- and feeder layer-free culture conditions. Baharvand H, Totonchi M, Taei A, Seifinejad A, Aghdami N, Salekdeh GH. Methods Mol Biol. 2010 . 584():425-43. PubMed |
| EOS lentiviral vector selection system for human induced pluripotent stem cells. Hotta A, Cheung AY, Farra N, Garcha K, Chang WY, Pasceri P, Stanford WL, Ellis J. Nat Protoc. 2009 . 4(12):1828-44. PubMed |
| Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. Germanguz I, Sedan O, Zeevi-Levin N, Shtrichman R, Barak E, Ziskind A, Eliyahu S, Meiry G, Amit M, Itskovitz-Eldor J, Binah O. J Cell Mol Med. 2011 Jan;15(1):38-51. doi: 10.1111/j.1582-4934.2009.00996.x. PubMed |
| Generation of human induced pluripotent stem cells bearing an anti-HIV transgene by a lentiviral vector carrying an internal murine leukemia virus promoter. Kamata M, Shirley L, Liang M, Nagaoka Y, Chen IS. Hum Gene Ther. 2010 Jun 5. ():. PubMed |
| Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Yehezkel S, Rebibo-Sabbah A, Segev Y, Tzukerman M, Shaked R, Huber I, Gepstein L, Skorecki K, Selig S. Epigenetics. 2011 Jan;6(1):63-75. doi: 10.4161/epi.6.1.13390. Epub 2011 Jan 1. PubMed |
| Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Chamberlain SJ, Chen PF, Ng KY, Bourgois-Rocha F, Lemtiri-Chlieh F, Levine ES, Lalande M. Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17668-73. doi: 10.1073/pnas.1004487107. Epub 2010 Sep 27. PubMed |
| A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Chia NY, Chan YS, Feng B, Lu X, Orlov YL, Moreau D, Kumar P, Yang L, Jiang J, Lau MS, Huss M, Soh BS, Kraus P, Li P, Lufkin T, Lim B, Clarke ND, Bard F, Ng HH. Nature. 2010 Nov 11;468(7321):316-20. doi: 10.1038/nature09531. Epub 2010 Oct 17. PubMed |
| High-efficient generation of induced pluripotent stem cells from human astrocytes. Ruiz S, Brennand K, Panopoulos AD, Herrerias A, Gage FH, Izpisua-Belmonte JC. PLoS One. 2010 Dec 9;5(12):e15526. doi: 10.1371/journal.pone.0015526. PubMed |
| Modelling the long QT syndrome with induced pluripotent stem cells. Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, Feldman O, Gepstein A, Arbel G, Hammerman H, Boulos M, Gepstein L. Nature. 2011 Mar 10;471(7337):225-9. doi: 10.1038/nature09747. Epub 2011 Jan 16. PubMed |
| Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Liu GH, Barkho BZ, Ruiz S, Diep D, Qu J, Yang SL, Panopoulos AD, Suzuki K, Kurian L, Walsh C, Thompson J, Boue S, Fung HL, Sancho-Martinez I, Zhang K, Yates J 3rd, Izpisua Belmonte JC. Nature. 2011 Apr 14;472(7342):221-5. doi: 10.1038/nature09879. Epub 2011 Feb 23. PubMed |
| Somatic coding mutations in human induced pluripotent stem cells. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E, Lee JH, Loh YH, Manos PD, Montserrat N, Panopoulos AD, Ruiz S, Wilbert ML, Yu J, Kirkness EF, Izpisua Belmonte JC, Rossi DJ, Thomson JA, Eggan K, Daley GQ, Goldstein LS, Zhang K. Nature. 2011 Mar 3;471(7336):63-7. doi: 10.1038/nature09805. PubMed |
| Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells. Sugii S, Kida Y, Berggren WT, Evans RM. Nat Protoc. 2011 Mar;6(3):346-58. doi: 10.1038/nprot.2010.199. Epub 2011 Feb 24. PubMed |
| A bioinformatic assay for pluripotency in human cells. Muller FJ, Schuldt BM, Williams R, Mason D, Altun G, Papapetrou EP, Danner S, Goldmann JE, Herbst A, Schmidt NO, Aldenhoff JB, Laurent LC, Loring JF. Nat Methods. 2011 Apr;8(4):315-7. doi: 10.1038/nmeth.1580. Epub 2011 Mar 6. PubMed |
| Rapid and highly efficient generation of induced pluripotent stem cells from human umbilical vein endothelial cells. Panopoulos AD, Ruiz S, Yi F, Herrerias A, Batchelder EM, Izpisua Belmonte JC. PLoS One. 2011;6(5):e19743. doi: 10.1371/journal.pone.0019743. Epub 2011 May 16. PubMed |
| Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells. Lemonnier T, Blanchard S, Toli D, Roy E, Bigou S, Froissart R, Rouvet I, Vitry S, Heard JM, Bohl D. Hum Mol Genet. 2011 Sep 15;20(18):3653-66. doi: 10.1093/hmg/ddr285. Epub 2011 Jun 17. PubMed |
| A novel strategy to derive iPS cells from porcine fibroblasts. Ruan W, Han J, Li P, Cao S, An Y, Lim B, Li N. Sci China Life Sci. 2011 Jun;54(6):553-9. doi: 10.1007/s11427-011-4179-5. Epub 2011 Jun 26. PubMed |
| Induced pluripotent stem cells from highly endangered species. Ben-Nun IF, Montague SC, Houck ML, Tran HT, Garitaonandia I, Leonardo TR, Wang YC, Charter SJ, Laurent LC, Ryder OA, Loring JF. Nat Methods. 2011 Sep 4;8(10):829-31. doi: 10.1038/nmeth.1706. PubMed |
| Induction of retinal pigment epithelial cells from monkey iPS cells. Okamoto S, Takahashi M. Invest Ophthalmol Vis Sci. 2011 Nov 11;52(12):8785-90. doi: 10.1167/iovs.11-8129. PubMed |
| The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Panopoulos AD, Yanes O, Ruiz S, Kida YS, Diep D, Tautenhahn R, Herrerias A, Batchelder EM, Plongthongkum N, Lutz M, Berggren WT, Zhang K, Evans RM, Siuzdak G, Izpisua Belmonte JC. Cell Res. 2012 Jan;22(1):168-77. doi: 10.1038/cr.2011.177. Epub 2011 Nov 8. PubMed |
| FGF signalling inhibits neural induction in human embryonic stem cells. Greber B, Coulon P, Zhang M, Moritz S, Frank S, Muller-Molina AJ, Arauzo-Bravo MJ, Han DW, Pape HC, Scholer HR. EMBO J. 2011 Nov 15;30(24):4874-84. doi: 10.1038/emboj.2011.407. PubMed |
| Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease. Koch P, Breuer P, Peitz M, Jungverdorben J, Kesavan J, Poppe D, Doerr J, Ladewig J, Mertens J, Tuting T, Hoffmann P, Klockgether T, Evert BO, Wullner U, Brustle O. Nature. 2011 Nov 23;480(7378):543-6. doi: 10.1038/nature10671. PubMed |
| Selecting and isolating colonies of human induced pluripotent stem cells reprogrammed from adult fibroblasts. Polak U, Hirsch C, Ku S, Gottesfeld J, Dent SY, Napierala M. J Vis Exp. 2012 Feb 20;(60). pii: 3416. doi: 10.3791/3416. PubMed |
| Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Oki K, Tatarishvili J, Wood J, Koch P, Wattananit S, Mine Y, Monni E, Tornero D, Ahlenius H, Ladewig J, Brustle O, Lindvall O, Kokaia Z. Stem Cells. 2012 Jun;30(6):1120-33. doi: 10.1002/stem.1104. PubMed |
| Small molecules greatly improve conversion of human-induced pluripotent stem cells to the neuronal lineage. Mak SK, Huang YA, Iranmanesh S, Vangipuram M, Sundararajan R, Nguyen L, Langston JW, Schule B. Stem Cells Int. 2012;2012:140427. doi: 10.1155/2012/140427. Epub 2012 Apr 10. PubMed |
| Screening of human pluripotent stem cells using CGH and FISH reveals low-grade mosaic aneuploidy and a recurrent amplification of chromosome 1q. Dekel-Naftali M, Aviram-Goldring A, Litmanovitch T, Shamash J, Reznik-Wolf H, Laevsky I, Amit M, Itskovitz-Eldor J, Yung Y, Hourvitz A, Schiff E, Rienstein S. Eur J Hum Genet. 2012 Dec;20(12):1248-55. doi: 10.1038/ejhg.2012.128. Epub 2012 Jun 20. PubMed |
| Advances in induced pluripotent stem cell technologies. Pal R, Rao M, Vemuri MC, Verma P, Dinnyes A. Stem Cells Int. 2012;2012:850201. doi: 10.1155/2012/850201. Epub 2012 Jun 19. PubMed |
| Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species. Imamura M, Okuno H, Tomioka I, Kawamura Y, Lin ZY, Nakajima R, Akamatsu W, Okano HJ, Matsuzaki Y, Sasaki E, Okano H. Methods Mol Biol. 2012;925:21-48. doi: 10.1007/978-1-62703-011-3_2. PubMed |
| Reversal of aberrant cancer methylome and transcriptome upon direct reprogramming of lung cancer cells. Mahalingam D, Kong CM, Lai J, Tay LL, Yang H, Wang X. Sci Rep. 2012;2:592. doi: 10.1038/srep00592. Epub 2012 Aug 21. PubMed |
| Generation of human induced pluripotent stem cells from urine samples. Zhou T, Benda C, Dunzinger S, Huang Y, Ho JC, Yang J, Wang Y, Zhang Y, Zhuang Q, Li Y, Bao X, Tse HF, Grillari J, Grillari-Voglauer R, Pei D, Esteban MA. Nat Protoc. 2012 Dec;7(12):2080-9. doi: 10.1038/nprot.2012.115. Epub 2012 Nov 8. PubMed |
| A PRC2-dependent repressive role of PRDM14 in human embryonic stem cells and induced pluripotent stem cell reprogramming. Chan YS, Goke J, Lu X, Venkatesan N, Feng B, Su IH, Ng HH. Stem Cells. 2013 Apr;31(4):682-92. doi: 10.1002/stem.1307. PubMed |
| Analysis of protein-coding mutations in hiPSCs and their possible role during somatic cell reprogramming. Ruiz S, Gore A, Li Z, Panopoulos AD, Montserrat N, Fung HL, Giorgetti A, Bilic J, Batchelder EM, Zaehres H, Scholer HR, Zhang K, Izpisua Belmonte JC. Nat Commun. 2013;4:1382. doi: 10.1038/ncomms2381. PubMed |
| Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Reinhardt P, Schmid B, Burbulla LF, Schondorf DC, Wagner L, Glatza M, Hoing S, Hargus G, Heck SA, Dhingra A, Wu G, Muller S, Brockmann K, Kluba T, Maisel M, Kruger R, Berg D, Tsytsyura Y, Thiel CS, Psathaki OE, Klingauf J, Kuhlmann T, Klewin M, Muller H, Gasser T, Scholer HR, Sterneckert J. Cell Stem Cell. 2013 Mar 7;12(3):354-67. doi: 10.1016/j.stem.2013.01.008. PubMed |
| Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. Reinhardt P, Glatza M, Hemmer K, Tsytsyura Y, Thiel CS, Hoing S, Moritz S, Parga JA, Wagner L, Bruder JM, Wu G, Schmid B, Ropke A, Klingauf J, Schwamborn JC, Gasser T, Scholer HR, Sterneckert J. PLoS One. 2013;8(3):e59252. doi: 10.1371/journal.pone.0059252. Epub 2013 Mar 22. PubMed |
| Reprogramming activity of NANOGP8, a NANOG family member widely expressed in cancer. Palla AR, Piazzolla D, Abad M, Li H, Dominguez O, Schonthaler HB, Wagner EF, Serrano M. Oncogene. 2014 May 8;33(19):2513-9. doi: 10.1038/onc.2013.196. Epub 2013 Jun 10. PubMed |
| Induced pluripotent stem cells derived from rabbits exhibit some characteristics of naive pluripotency. Osteil P, Tapponnier Y, Markossian S, Godet M, Schmaltz-Panneau B, Jouneau L, Cabau C, Joly T, Blachere T, Gocza E, Bernat A, Yerle M, Acloque H, Hidot S, Bosze Z, Duranthon V, Savatier P, Afanassieff M. Biol Open. 2013 May 10;2(6):613-28. doi: 10.1242/bio.20134242. Print 2013 Jun 15. PubMed |
| Differentiation of human induced pluripotent stem cells into brown and white adipocytes: role of Pax3. Mohsen-Kanson T, Hafner AL, Wdziekonski B, Takashima Y, Villageois P, Carriere A, Svensson M, Bagnis C, Chignon-Sicard B, Svensson PA, Casteilla L, Smith A, Dani C. Stem Cells. 2014 Jun;32(6):1459-67. doi: 10.1002/stem.1607. PubMed |
| A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells. Goh PA, Caxaria S, Casper C, Rosales C, Warner TT, Coffey PJ, Nathwani AC. PLoS One. 2013 Nov 26;8(11):e81622. doi: 10.1371/journal.pone.0081622. eCollection 2013. PubMed |
| Gammaretroviral vector encoding a fluorescent marker to facilitate detection of reprogrammed human fibroblasts during iPSC generation. Srinivasakumar N, Zaboikin M, Tidball AM, Aboud AA, Neely MD, Ess KC, Bowman AB, Schuening FG. PeerJ. 2013 Dec 10;1:e224. doi: 10.7717/peerj.224. eCollection 2013. PubMed |
| Foxd1 is a mediator and indicator of the cell reprogramming process. Koga M, Matsuda M, Kawamura T, Sogo T, Shigeno A, Nishida E, Ebisuya M. Nat Commun. 2014;5:3197. doi: 10.1038/ncomms4197. PubMed |
| Physiological characterisation of human iPS-derived dopaminergic neurons. Hartfield EM, Yamasaki-Mann M, Ribeiro Fernandes HJ, Vowles J, James WS, Cowley SA, Wade-Martins R. PLoS One. 2014 Feb 21;9(2):e87388. doi: 10.1371/journal.pone.0087388. eCollection 2014. PubMed |
| Human induced pluripotent stem cells improve recovery in stroke-injured aged rats. Tatarishvili J, Oki K, Monni E, Koch P, Memanishvili T, Buga AM, Verma V, Popa-Wagner A, Brustle O, Lindvall O, Kokaia Z. Restor Neurol Neurosci. 2014;32(4):547-58. doi: 10.3233/RNN-140404. PubMed |
| Derivation of mesenchymal stromal cells from canine induced pluripotent stem cells by inhibition of the TGFbeta/activin signaling pathway. Whitworth DJ, Frith JE, Frith TJ, Ovchinnikov DA, Cooper-White JJ, Wolvetang EJ. Stem Cells Dev. 2014 Dec 15;23(24):3021-33. doi: 10.1089/scd.2013.0634. PubMed |
| Generation of Induced Pluripotent Stem Cells in Rabbits. Afanassieff M, Tapponnier Y, Savatier P. Methods Mol Biol. 2014 Nov 21. PubMed |
| Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential. Chuang CY, Huang MC, Chen HF, Tseng LH, Yu CY, Stone L, Huang HP, Ho HN, Kuo HC. Stem Cell Res Ther. 2015 Feb 27;6:14. doi: 10.1186/s13287-015-0005-5. PubMed |
| Generation of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cells. Fuerstenau-Sharp M, Zimmermann ME, Stark K, Jentsch N, Klingenstein M, Drzymalski M, Wagner S, Maier LS, Hehr U, Baessler A, Fischer M, Hengstenberg C. PLoS One. 2015 May 13;10(5):e0126596. doi: 10.1371/journal.pone.0126596. eCollection 2015. PubMed |
| Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy. Doerr J, Bockenhoff A, Ewald B, Ladewig J, Eckhardt M, Gieselmann V, Matzner U, Brustle O, Koch P. Mol Ther. 2015 Jun 10. doi: 10.1038/mt.2015.106. PubMed |
| Derivation of Canine Induced Pluripotent Stem Cells. Baird A, Barsby T, Guest DJ. Reprod Domest Anim. 2015 Aug;50(4):669-76. doi: 10.1111/rda.12562. Epub 2015 Jun 12. PubMed |
| A panel of induced pluripotent stem cells from chimpanzees: a resource for comparative functional genomics. Gallego Romero I, Pavlovic BJ, Hernando-Herraez I, Zhou X, Ward MC, Banovich NE, Kagan CL, Burnett JE, Huang CH, Mitrano A, Chavarria CI, Friedrich Ben-Nun I, Li Y, Sabatini K, Leonardo TR, Parast M, Marques-Bonet T, Laurent LC, Loring JF, Gilad Y. Elife. 2015 Jun 23;4:e07103. doi: 10.7554/eLife.07103. PubMed |
| Modeling amyotrophic lateral sclerosis in pure human iPSc-derived motor neurons isolated by a novel FACS double selection technique. Toli D, Buttigieg D, Blanchard S, Lemonnier T, Lamotte d'Incamps B, Bellouze S, Baillat G, Bohl D, Haase G. Neurobiol Dis. 2015 Jun 21;82:269-280. doi: 10.1016/j.nbd.2015.06.011. PubMed |
| Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes - A Possible Biological Pacemaker. Saito Y, Nakamura K, Yoshida M, Sugiyama H, Ohe T, Kurokawa J, Furukawa T, Takano M, Nagase S, Morita H, Kusano KF, Ito H. PLoS One. 2015 Sep 18;10(9):e0138193. doi: 10.1371/journal.pone.0138193. eCollection 2015. PubMed |
| Induction of Pluripotency in Astrocytes through a Neural Stem Cell-like State. Nakajima-Koyama M, Lee J, Ohta S, Yamamoto T, Nishida E. J Biol Chem. 2015 Dec 25;290(52):31173-88. doi: 10.1074/jbc.M115.683466. Epub 2015 Nov 9. PubMed |
| Generation of Induced Pluripotent Stem Cells from Mammalian Endangered Species. Friedrich Ben-Nun I, Montague SC, Houck ML, Ryder O, Loring JF. Methods Mol Biol. 2015;1330:101-9. doi: 10.1007/978-1-4939-2848-4_10. PubMed |
| DPPA5 Supports Pluripotency and Reprogramming by Regulating NANOG Turnover. Qian X, Kim JK, Tong W, Villa-Diaz LG, Krebsbach PH. Stem Cells. 2015 Dec 13. doi: 10.1002/stem.2252. PubMed |
| Equine Induced Pluripotent Stem Cells have a Reduced Tendon Differentiation Capacity Compared to Embryonic Stem Cells. Bavin EP, Smith O, Baird AE, Smith LC, Guest DJ. Front Vet Sci. 2015 Nov 16;2:55. doi: 10.3389/fvets.2015.00055. eCollection 2015. PubMed |
| Soluble expression and stability enhancement of transcription factors using 30Kc19 cell-penetrating protein. Ryu J, Park HH, Park JH, Lee HJ, Rhee WJ, Park TH. Appl Microbiol Biotechnol. 2015 Dec 15. PubMed |
| Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction. Malan D, Zhang M, Stallmeyer B, Muller J, Fleischmann BK, Schulze-Bahr E, Sasse P, Greber B. Basic Res Cardiol. 2016 Mar;111(2):14. doi: 10.1007/s00395-016-0530-0. Epub 2016 Jan 23. PubMed |
| Whole-genome mutational burden analysis of three pluripotency induction methods. Bhutani K, Nazor KL, Williams R, Tran H, Dai H, Dzakula Z, Cho EH, Pang AW, Rao M, Cao H, Schork NJ, Loring JF. Nat Commun. 2016 Feb 19;7:10536. doi: 10.1038/ncomms10536. PubMed |
| Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Sancho-Martinez I, Nivet E, Xia Y, Hishida T, Aguirre A, Ocampo A, Ma L, Morey R, Krause MN, Zembrzycki A, Ansorge O, Vazquez-Ferrer E, Dubova I, Reddy P, Lam D, Hishida Y, Wu MZ, Esteban CR, O'Leary D, Wahl GM, Verma IM, Laurent LC, Izpisua Belmonte JC. Nat Commun. 2016 Feb 22;7:10743. doi: 10.1038/ncomms10743. PubMed |
| Generation of an iPS cell line from bone marrow derived mesenchymal stromal cells from an elderly patient. Megges M, Geissler S, Duda GN, Adjaye J. Stem Cell Res. 2015 Nov;15(3):565-8. doi: 10.1016/j.scr.2015.10.003. Epub 2015 Oct 9. PubMed |
| Generation of iPSC lines from a Nijmegen Breakage Syndrome patient. Mlody B, Adjaye J. Stem Cell Res. 2015 Nov;15(3):629-32. doi: 10.1016/j.scr.2015.10.013. Epub 2015 Oct 23. PubMed |
| Generation of iPSC lines from primary human chorionic villi cells. Lichtner B, Matz P, Adjaye J. Stem Cell Res. 2015 Nov;15(3):697-9. doi: 10.1016/j.scr.2015.10.011. Epub 2015 Oct 23. PubMed |
| Generation of iPSC lines from primary human amniotic fluid cells. Drews K, Matz P, Adjaye J. Stem Cell Res. 2015 Nov;15(3):712-4. doi: 10.1016/j.scr.2015.11.003. Epub 2015 Nov 11. PubMed |
| The CCR4-NOT deadenylase activity contributes to generation of induced pluripotent stem cells. Zukeran A, Takahashi A, Takaoka S, Mohamed HM, Suzuki T, Ikematsu S, Yamamoto T. Biochem Biophys Res Commun. 2016 May 27;474(2):233-9. doi: 10.1016/j.bbrc.2016.03.119. Epub 2016 Mar 30. PubMed |
| Vitamin C promotes pluripotency of human induced pluripotent stem cells via the histone demethylase JARID1A. Eid W, Abdel-Rehim W. Biol Chem. 2016 Nov 1;397(11):1205-1213. doi: 10.1515/hsz-2016-0181. PubMed |
| Generation and characterization of human iPSC line generated from mesenchymal stem cells derived from adipose tissue. Zapata-Linares N, Rodriguez S, Mazo M, Abizanda G, Andreu EJ, Barajas M, Prosper F, Rodriguez-Madoz JR. Stem Cell Res. 2016 Jan;16(1):20-3. doi: 10.1016/j.scr.2015.12.002. Epub 2015 Dec 2. PubMed |
| A balance between elongation and trimming regulates telomere stability in stem cells. Rivera T, Haggblom C, Cosconati S, Karlseder J. Nat Struct Mol Biol. 2017 Jan;24(1):30-39. doi: 10.1038/nsmb.3335. Epub 2016 Dec 5. PubMed |
| PHB Associates with the HIRA Complex to Control an Epigenetic-Metabolic Circuit in Human ESCs. Zhu Z, Li C, Zeng Y, Ding J, Qu Z, Gu J, Ge L, Tang F, Huang X, Zhou C, Wang P, Zheng D, Jin Y. Cell Stem Cell. 2016 Nov 17. pii: S1934-5909(16)30398-8. doi: 10.1016/j.stem.2016.11.002. PubMed |
| Systematic evaluation of markers used for the identification of human induced pluripotent stem cells. Bharathan SP, Manian KV, Aalam SM, Palani D, Deshpande PA, Pratheesh MD, Srivastava A, Velayudhan SR. Biol Open. 2017 Jan 15;6(1):100-108. doi: 10.1242/bio.022111. PubMed |
| SOX17 Regulates Conversion of Human Fibroblasts Into Endothelial Cells and Erythroblasts by Dedifferentiation Into CD34+ Progenitor Cells. Zhang L, Jambusaria A, Hong Z, Marsboom G, Toth PT, Herbert BS, Malik AB, Rehman J. Circulation. 2017 Jun 20;135(25):2505-2523. doi: 10.1161/CIRCULATIONAHA.116.025722. Epub 2017 Apr 5. PubMed |
| Susceptibility of Human Oral Squamous Cell Carcinoma (OSCC) H103 and H376 cell lines to Retroviral OSKM mediated reprogramming. Verusingam ND, Yeap SK, Ky H, Paterson IC, Khoo SP, Cheong SK, Ong AHK, Kamarul T. PeerJ. 2017 Apr 13;5:e3174. doi: 10.7717/peerj.3174. eCollection 2017. PubMed |
| Identification and characterization of secreted factors that are upregulated during somatic cell reprogramming. Bansho Y, Lee J, Nishida E, Nakajima-Koyama M. FEBS Lett. 2017 Jun;591(11):1584-1600. doi: 10.1002/1873-3468.12665. Epub 2017 May 22. PubMed |
| Generation of a pig induced pluripotent stem cell (piPSC) line from embryonic fibroblasts by incorporating LIN28 to the four transcriptional factor-mediated reprogramming: VSMUi001-D. Chakritbudsabong W, Sariya L, Pamonsupornvichit S, Pronarkngver R, Chaiwattanarungruengpaisan S, Ferreira JN, Setthawong P, Phakdeedindan P, Techakumphu M, Tharasanit T, Rungarunlert S. Stem Cell Res. 2017 Oct;24:21-24. doi: 10.1016/j.scr.2017.08.005. Epub 2017 Aug 5. PubMed |
| Induced Pluripotent Stem Cells from Ovarian Tissue. Salas S, Ng N, Gerami-Naini B, Anchan RM. Curr Protoc Hum Genet. 2017 Oct 18;95:21.10.1-21.10.22. doi: 10.1002/cphg.47. PubMed |
| Sox2 modulates motility and enhances progression of colorectal cancer via the Rho-ROCK signaling pathway. Zheng J, Xu L, Pan Y, Yu S, Wang H, Kennedy D, Zhang Y. Oncotarget. 2017 Oct 10;8(58):98635-98645. doi: 10.18632/oncotarget.21709. eCollection 2017 Nov 17. PubMed |
| Amenable epigenetic traits of dental pulp stem cells underlie high capability of xeno-free episomal reprogramming. Thekkeparambil Chandrabose S, Sriram S, Subramanian S, Cheng S, Ong WK, Rozen S, Kasim NHA, Sugii S. Stem Cell Res Ther. 2018 Mar 20;9(1):68. doi: 10.1186/s13287-018-0796-2. PubMed |
| Osteoblast differentiation of equine induced pluripotent stem cells. Baird A, Lindsay T, Everett A, Iyemere V, Paterson YZ, McClellan A, Henson FMD, Guest DJ. Biol Open. 2018 May 10;7(5). pii: bio.033514. doi: 10.1242/bio.033514. PubMed |
| Generation of hepatocyte- and endocrine pancreatic-like cells from human induced endodermal progenitor cells. Sambathkumar R, Akkerman R, Dastidar S, Roelandt P, Kumar M, Bajaj M, Mestre Rosa AR, Helsen N, Vanslembrouck V, Kalo E, Khurana S, Laureys J, Gysemans C, Faas MM, de Vos P, Verfaillie CM. PLoS One. 2018 May 11;13(5):e0197046. doi: 10.1371/journal.pone.0197046. eCollection 2018. PubMed |
| miR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via PAI-1-Sox2 axis. Zhang Y, Pan Y, Xie C, Zhang Y. Cell Death Dis. 2018 Jul 10;9(7):777. doi: 10.1038/s41419-018-0778-4. PubMed |
| Rabbit induced pluripotent stem cells retain capability of in vitro cardiac differentiation. Phakdeedindan P, Setthawong P, Tiptanavattana N, Rungarunlert S, Ingrungruanglert P, Israsena N, Techakumphu M, Tharasanit T. Exp Anim. 2019 Feb 26;68(1):35-47. doi: 10.1538/expanim.18-0074. Epub 2018 Aug 8. PubMed |
| Tbx1 represses Mef2c gene expression and is correlated with histone 3 deacetylation of the anterior heart field enhancer. Pane LS, Fulcoli FG, Cirino A, Altomonte A, Ferrentino R, Bilio M, Baldini A. Dis Model Mech. 2018 Aug 30;11(9). pii: 11/9/dmm029967. doi: 10.1242/dmm.029967. PubMed |
| Generation of an induced pluripotent stem cell (iPSC) line from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Leu328Val) mutation. Schwarz N, Uysal B, Rosa F, Loffler H, Mau-Holzmann UA, Liebau S, Lerche H. Stem Cell Res. 2018 Dec;33:6-9. doi: 10.1016/j.scr.2018.08.019. Epub 2018 Aug 31. PubMed |
| Generation of porcine induced-pluripotent stem cells from Sertoli cells. Setthawong P, Phakdeedindan P, Tiptanavattana N, Rungarunlert S, Techakumphu M, Tharasanit T. Theriogenology. 2019 Mar 15;127:32-40. doi: 10.1016/j.theriogenology.2018.12.033. Epub 2018 Dec 21. PubMed |
| Defining the Functional Role of NaV1.7 in Human Nociception. McDermott LA, Weir GA, Themistocleous AC, Segerdahl AR, Blesneac I, Baskozos G, Clark AJ, Millar V, Peck LJ, Ebner D, Tracey I, Serra J, Bennett DL. Neuron. 2019 Mar 6;101(5):905-919.e8. doi: 10.1016/j.neuron.2019.01.047. Epub 2019 Feb 19. PubMed |
| Human Pluripotent Stem Cell-Derived Tumor Model Uncovers the Embryonic Stem Cell Signature as a Key Driver in Atypical Teratoid/Rhabdoid Tumor. Terada Y, Jo N, Arakawa Y, Sakakura M, Yamada Y, Ukai T, Kabata M, Mitsunaga K, Mineharu Y, Ohta S, Nakagawa M, Miyamoto S, Yamamoto T, Yamada Y. Cell Rep. 2019 Mar 5;26(10):2608-2621.e6. doi: 10.1016/j.celrep.2019.02.009. PubMed |
| Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene. Mura M, Pisano F, Stefanello M, Ginevrino M, Boni M, Calabro F, Crotti L, Valente EM, Schwartz PJ, Brink PA, Gnecchi M. Stem Cell Res. 2019 Apr;36:101416. doi: 10.1016/j.scr.2019.101416. Epub 2019 Mar 6. PubMed |
| Therapeutic Potential of Patient iPSC-Derived iMelanocytes in Autologous Transplantation. Liu LP, Li YM, Guo NN, Li S, Ma X, Zhang YX, Gao Y, Huang JL, Zheng DX, Wang LY, Xu H, Hui L, Zheng YW. Cell Rep. 2019 Apr 9;27(2):455-466.e5. doi: 10.1016/j.celrep.2019.03.046. PubMed |
| Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation. Mura M, Lee YK, Pisano F, Ginevrino M, Boni M, Calabro F, Crotti L, Valente EM, Schwartz PJ, Tse HF, Gnecchi M. Stem Cell Res. 2019 May;37:101431. doi: 10.1016/j.scr.2019.101431. Epub 2019 Mar 27. PubMed |
| Establishment of a human induced pluripotent stem cell (iPSC) line (HIHDNEi002-A) from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Arg297Gln) mutation. Schwarz N, Uysal B, Rosa F, Loffler H, Mau-Holzmann UA, Liebau S, Lerche H. Stem Cell Res. 2019 May;37:101445. doi: 10.1016/j.scr.2019.101445. Epub 2019 Apr 19. PubMed |
| Conversion of human and mouse fibroblasts into lung-like epithelial cells. Wong AP, Shojaie S, Liang Q, Xia S, Di Paola M, Ahmadi S, Bilodeau C, Garner J, Post M, Duchesneau P, Waddell TK, Bear CE, Nagy A, Rossant J. Sci Rep. 2019 Jun 21;9(1):9027. doi: 10.1038/s41598-019-45195-y. PubMed |
| Inducing Pluripotency in the Domestic Cat (Felis catus). Dutton LC, Dudhia J, Guest DJ, Connolly DJ. Stem Cells Dev. 2019 Oct 1;28(19):1299-1309. doi: 10.1089/scd.2019.0142. Epub 2019 Sep 5. PubMed |
| Generation of an induced pluripotent stem cell (iPSC) line (HIHDNEi003-A) from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Thr374Ala) mutation. Uysal B, Loffler H, Rosa F, Lerche H, Schwarz N. Stem Cell Res. 2019 Oct;40:101543. doi: 10.1016/j.scr.2019.101543. Epub 2019 Aug 21. PubMed |
| Combined Dendritic and Axonal Deterioration Are Responsible for Motoneuronopathy in Patient-Derived Neuronal Cell Models of Chorea-Acanthocytosis. Glass H, Neumann P, Pal A, Reinhardt P, Storch A, Sterneckert J, Hermann A. Int J Mol Sci. 2020 Mar 5;21(5). pii: ijms21051797. doi: 10.3390/ijms21051797. PubMed |
| Generation of a human iPSC line (MPIi006-A) from a patient with Pelizaeus-Merzbacher disease. Kim KP, Yoon J, Shin B, Ropke A, Han DW, Scholer HR. Stem Cell Res. 2020 Jul;46:101839. doi: 10.1016/j.scr.2020.101839. Epub 2020 May 7. PubMed |
| Reprogramming competence of OCT factors is determined by transactivation domains. Kim KP, Wu Y, Yoon J, Adachi K, Wu G, Velychko S, MacCarthy CM, Shin B, Ropke A, Arauzo-Bravo MJ, Stehling M, Han DW, Gao Y, Kim J, Gao S, Scholer HR. Sci Adv. 2020 Sep 2;6(36). pii: 6/36/eaaz7364. doi: 10.1126/sciadv.aaz7364. Print 2020 Sep. PubMed |
| Generation of a human iPSC line (MPIi007-A) from a patient with Metachromatic leukodystrophy. Kim KP, Yoon J, Kim J, Ropke A, Shin B, Wook Han D, Greber B, Scholer HR. Stem Cell Res. 2020 Oct;48:101993. doi: 10.1016/j.scr.2020.101993. Epub 2020 Sep 13. PubMed |
| Activation of Wnt/beta-catenin signalling and HIF1alpha stabilisation alters pluripotency and differentiation/proliferation properties of human-induced pluripotent stem cells. Wei H, Beeson GC, Ye Z, Zhang J, Yao H, Damon B, Morad M. Biol Cell. 2021 Mar;113(3):133-145. doi: 10.1111/boc.202000055. Epub 2020 Dec 16. PubMed |
| An induced pluripotent stem cell line (CSUi004-A) from skin fibroblasts of a healthy individual. Wang L, Zhao H, Wu J, Ren J, Luo H, Zuo X, Chen Q, Tang Y. Stem Cell Res. 2021 May;53:102336. doi: 10.1016/j.scr.2021.102336. Epub 2021 Apr 8. PubMed |
| Molecular signature and colony morphology affect in vitro pluripotency of porcine induced pluripotent stem cells. Setthawong P, Phakdeedindan P, Techakumphu M, Tharasanit T. Reprod Domest Anim. 2021 Aug;56(8):1104-1116. doi: 10.1111/rda.13954. Epub 2021 May 30. PubMed |
| Structurally-discovered KLF4 variants accelerate and stabilize reprogramming to pluripotency. Borisova E, Nishimura K, An Y, Takami M, Li J, Song D, Matsuo-Takasaki M, Luijkx D, Aizawa S, Kuno A, Sugihara E, Sato TA, Yumoto F, Terada T, Hisatake K, Hayashi Y. iScience. 2021 Dec 14;25(1):103525. doi: 10.1016/j.isci.2021.103525. eCollection 2022 Jan 21. PubMed |
| Amphiregulin mediates non-cell-autonomous effect of senescence on reprogramming. von Joest M, Chen C, Douche T, Chantrel J, Chiche A, Gianetto QG, Matondo M, Li H. Cell Rep. 2022 Jul 12;40(2):111074. doi: 10.1016/j.celrep.2022.111074. PubMed |
| Enhanced efficiency of generating human-induced pluripotent stem cells using Lin28-30Kc19 fusion protein. Son B, Yoon H, Ryu J, Lee H, Joo J, Park HH, Park TH. Front Bioeng Biotechnol. 2022 Jul 22;10:911614. doi: 10.3389/fbioe.2022.911614. eCollection 2022. PubMed |
| Equine induced pluripotent stem cells are responsive to inflammatory cytokines before and after differentiation into musculoskeletal cell types. Palomino Lago E, Jelbert ER, Baird A, Lam PY, Guest DJ. In Vitro Cell Dev Biol Anim. 2023 Aug;59(7):514-527. doi: 10.1007/s11626-023-00800-3. Epub 2023 Aug 15. PubMed |
| Ultrasound-triggered three dimensional hyaluronic acid hydrogel promotes in vitro and in vivo reprogramming into induced pluripotent stem cells. Kim D, Lee MJ, Arai Y, Ahn J, Lee GW, Lee SH. Bioact Mater. 2024 May 9;38:331-345. doi: 10.1016/j.bioactmat.2024.05.011. eCollection 2024 Aug. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.